• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Chief Financial Officer Jantzen Beth

    12/16/25 4:05:28 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary
    Get the next $BNBX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Jantzen Beth

    (Last) (First) (Middle)
    50 HEALTH SCIENCES DRIVE

    (Street)
    STONY BROOK NY 11790

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    BNB PLUS CORP. [ BNBX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    12/15/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Incentive Stock Option (right to buy) $2.52 12/15/2025 A 42,194 (1) 12/15/2035 Common Stock 42,194 $0 42,194 D
    Non-Qualified Stock Option (right to buy) $2.52 12/15/2025 A 42,194 (1) 12/15/2035 Common Stock 42,194 $0 42,194 D
    Explanation of Responses:
    1. The options vest 25% per quarter commencing 90 days from the grant date.
    /s/ Beth Jantzen 12/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BNBX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNBX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BNBX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Digital Asset Virtual Investor Conference: Presentations Now Available for Online Viewing

    NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Digital Asset Virtual Conference, held January 27th are now available for online viewing. REGISTER AND VIEW PRESENTATIONS HERE The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section. Select companies are accepting 1x1 management meeting requests through January 30th. Please schedule 1x1 meetings here January 27th PresentationTicker(s)Africa Bitcoin Corporation Limited(OTCQB:AFBCF, JSE: BAC))VersaBank(NASDAQ:VBNK

    1/28/26 8:35:00 AM ET
    $AVX
    $BNBX
    $VBNK
    Finance: Consumer Services
    Finance
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

    Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua Kruger will present live at the Digital Asset Virtual Investor Conference hosted by Virtual InvestorConferences.com, on January 27th, 2026 at 1:00PM EST. DATE: January 27th, 2026 TIME: 1:00PM EST Register here Mr. Horsman and Mr. Kruger will be available for 1x1 meetings on January 27-29. Participants may schedule 1x1 Meetings here. The Digital Asset Virtual Investor Conference is a live,

    1/27/26 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua Kruger will present live at the Digital Asset Virtual Investor Conference hosted by Virtual InvestorConferences.com, on January 27th, 2026 at 1:00PM EST. DATE: January 27th, 2026 TIME: 1:00PM EST Register here Mr. Horsman and Mr. Kruger will be available for 1x1 meetings on January 27-29. Participants may schedule 1x1 Meetings Here The Digital Asset Virtual Investor Conference is a live, interactive online event where investors are invited to ask the company questions in real-time. If att

    1/27/26 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    SEC Filings

    View All

    SEC Form S-8 filed by BNB Plus Corp.

    S-8 - BNB PLUS CORP. (0000744452) (Filer)

    1/30/26 4:06:16 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. filed SEC Form 8-K: Leadership Update

    8-K - BNB PLUS CORP. (0000744452) (Filer)

    1/22/26 4:10:46 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    SEC Form 424B3 filed by BNB Plus Corp.

    424B3 - BNB PLUS CORP. (0000744452) (Filer)

    12/30/25 8:27:25 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Jantzen Beth

    4 - BNB PLUS CORP. (0000744452) (Issuer)

    12/16/25 4:05:28 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    SEC Form 4 filed by Chief Executive Officer Shorrock Clay

    4 - BNB PLUS CORP. (0000744452) (Issuer)

    12/16/25 4:05:49 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    New insider Kruger Joshua claimed ownership of 75,302 shares (SEC Form 3)

    3 - BNB PLUS CORP. (0000744452) (Issuer)

    11/19/25 7:36:22 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Leadership Updates

    Live Leadership Updates

    View All

    Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

    Rebrand Aligned with Yield-Focused BNB Treasury and BNBX Ticker Appointment Strengthens DeFi Leadership Applied DNA Sciences, Inc. (NASDAQ:BNBX) (the "Company") today announced that it will change its name to BNB Plus Corp. ("BNB Plus"), reflecting the Company's commitment to delivering a yield-optimized, BNB-based digital asset treasury strategy leveraging the Binance ecosystem. Alongside the rebrand, the Company also announced the appointment of Josh Kruger as Chairman of the Board. Mr. Kruger has deep expertise in managing blockchain-native assets for yield and capital efficiency. He is the founder of OnChain Alpha and previously served as Head of Trading at Coral Capital, which wa

    11/17/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Financials

    Live finance-specific insights

    View All

    BNB Plus Provides BNB Treasury and Operational Updates

    Company Acquires 3,349 Additional BNB Tokens LineaRx Subsidiary Expected to Narrow Losses and Approach Profitability in FY26Q1 Company Launches New Corporate Website and Branding BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today provided a corporate update highlighting its recent strategic treasury growth, expected significant narrowing of losses at its LineaRx, Inc. ("LineaRx") subsidiary, and the launch of a new corporate website and branding. Significant Addition to BNB Treasury The Company has opportunistically deployed an additional approximately $3 million to acquire additional BNB tokens at an average price of approximately $895 per token, further strengthening the C

    12/9/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

    Company Launches BNBX.io to Provide Robust Real-Time Portfolio and Company Metrics Company Recently Closed Up to $58 Million Private Placement to Launch Yield-Focused BNB Treasury Applied DNA Sciences, Inc. (NASDAQ:BNBX) ( "BNBX" or the "Company") today announced the launch of BNBX.io, which provides real-time portfolio metrics updating the market on the Company's BNB treasury holdings, key valuation metrics, and detailed information about the capitalization structure of the Company (the "Dashboard"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028565774/en/ "The launch of our Dashboard reflects BNBX's commitment to re

    10/28/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

    Company Officially Launches Yield-Focused Digital Asset Treasury Strategy Streamlines Operations, Achieving Approximately $2.9 Million in Annualized Cost Savings Applied DNA Sciences, Inc. (NASDAQ:BNBX) ("Applied DNA", "BNBX" or the "Company"), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced the successful close of its previously announced private investment in public equity ("PIPE") financing led by institutional DeFi and TradFi investors. The PIPE resulted in gross proceeds of approximately $27 Million to the Company, before deducting placement agent fees and other offering e

    10/22/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary